Grail (GRAL) Change in Acquisitions & Divestments (2025)
Grail's (GRAL) quarterly Change in Acquisitions & Divestments came in at $306.5 million in Q3 2025, down 13.1% quarter-over-quarter from $352.7 million in Q2 2025.
Powered by 
Analysis
Grail (GRAL) Change in Acquisitions & Divestments (2025) Analysis & Trends
Grail (GRAL) has reported Change in Acquisitions & Divestments for 1 consecutive years, with $306.5 million the latest figure, recorded in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn |
| 10 | Grail | 3.61 Bn | 2.75 Bn | 21.34 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 306.50 Mn |
| Jun 30, 2025 | 352.70 Mn |
| Mar 31, 2025 | 235.20 Mn |